文献速递生殖医学

体外受精技术进展支持辅助生殖诊所采用新绩效指标,但不支持放弃以患者为中心的指标

Developments in IVF warrant the adoption of new performance indicators for ART clinics, but do not justify the abandonment of patient-centred measures.
PubMed 文献 · Hum Reprod · 2017-01-01

胚胎冷冻技术进步与对多胎妊娠的担忧改变了适宜体外受精的模式,促使SART和HFEA等国家报告体系采用新的辅助生殖诊所绩效指标。本文从统计学角度评述活产率的分母选择,认为应纳入所有周期(包括取消周期),并指出单一指标无法兼顾有效性与安全性,需一套清晰的相关结局指标。

要点

  • 应将所有周期纳入活产率分母,无论取卵和受精是否成功
  • 排除取消周期虽减少患者特征混杂,但去除了政策与绩效差异这一相关变异来源
  • 每胚胎活产率鼓励单胚胎移植但易被误读,因活产可能性与移植胚胎数不成比例

核心结论

  • 不可能提出一个同时涵盖有效性与安全性的单一指标,需要一套清晰、相关的结局指标,使不育患者能就是否治疗及何处治疗做出知情选择。

研究设计与样本

  • 本文以SART和HFEA的国家报告体系为案例,从统计学角度评述多种结局测量指标,并描述活产率计算中使用的几种分母。

主要发现

  • 活产率的分母包括基于特定取卵或周期启动的所有新鲜与冷冻移植程序计算的累积出生率,以及按每移植胚胎计算的活产率。
  • 利用两个体系的数据,作者认为无论取卵和受精是否成功,所有周期都应纳入分母。
  • 排除取消周期减少了患者特征混杂的影响,但也去除了作者认为代表相关变异来源的政策与绩效差异。
  • 向 prospective 患者展示基于卵巢刺激和移植政策 parity 的本质上假设性的绩效指标可能造成误导。
  • 每胚胎活产率虽有鼓励单胚胎移植的优点,但作者认为它容易被误读,因为活产可能性与移植胚胎数不成比例。

临床怎么用

  • 作者认为所有周期都应纳入活产率分母,无论取卵和受精是否成功。
  • 作者认为排除取消周期会去除政策与绩效差异这一相关变异来源。
  • 作者认为向 prospective 患者展示基于卵巢刺激和移植政策 parity 的假设性绩效指标可能造成误导。
  • 作者认为每胚胎活产率容易被误读,因为活产可能性与移植胚胎数不成比例。
  • 作者提出需要一套清晰、相关的结局指标,使不育患者能就是否治疗及何处治疗做出知情选择。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Recent advances in embryo freezing technology together with growing concerns over multiple births have shifted the paradigm of appropriate IVF. This has led to the adoption of new performance indicators for ART clinics by national reporting schemes, such as those curated by the Society for Assisted Reproductive Technology (SART) and the Human Fertilization and Embryology Authority (HFEA). Using these organizations as case studies, we review several outcome measures from a statistical perspective. We describe several denominators that are used to calculate live birth rates. These include cumulative birth rates calculated from all fresh and frozen transfer procedures arising from a particular egg collection or cycle initiation, and live birth rates calculated per embryo transferred. Using data from both schemes, we argue that all cycles should be included in the denominator, regardless of whether or not egg collection and fertilization were successful. Excluding cancelled cycles reduces the impact of confounding due to patient characteristics but also removes policy and performance differences which we argue represent relevant sources of variation. It may be misleading to present prospective patients with essentially hypothetical measures of performance predicated on parity of ovarian stimulation and transfer policies. Although live birth per embryo has the advantage of encouraging single embryo transfer, we argue that it is prone to misinterpretation. This is because the likelihood of live birth is not proportional to the number of embryos transferred. We conclude that it is not possible to present a single measure that encompasses both effectiveness and safety. Instead, we propose that a set of clear, relevant outcome indicators is necessary to enable subfertile patients to make informed choices regarding whether and where to be treated.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Wilkinson J, Roberts SA, Vail A, et al. Developments in IVF warrant the adoption of new performance indicators for ART clinics, but do not justify the abandonment of patient-centred measures. Hum Reprod. 2017. PMID: 28369394. doi:10.1093/humrep/dex063

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。